Skip to main content

Advertisement

SpringerLink
Log in

Social and medical risk factors associated with supportive needs in the first year following localized prostate cancer treatment

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

Individuals who completed treatment for prostate cancer (PCa) often report poor coping and practical concerns when adapting to new roles in their lives—and strong patient–provider communication is critical for this period. However, there is limited research identifying factors associated with supportive needs after the completion of PCa treatment. This study aimed to identify the social and medical risk factors associated with supportive needs for adapting among individuals who completed treatment for localized PCa.

Methods

Using baseline data from a study evaluating a web-based support system for patients in the first year following treatment for localized PCa, self-efficacy for re-entry (e.g., maintaining relationships, symptom management), medical interactions, and practical concerns (e.g., insurance, exercise) were assessed. Multivariable regression analyses were completed to identify risk factors for low readiness.

Results

Participants (N = 431) with lower health literacy or income or with depressive symptoms had lower self-efficacy for re-entry, more negative interactions with medical providers, and more practical concerns (ps < .05). Lastly, non-Hispanic White participants reported greater readiness compared with all other races (ps < .05).

Conclusions

Multiple social and medical risk factors are associated with greater supportive needs when adapting to new roles after PCa treatment. Understanding the risk factors for supportive needs in this period is critical. Future research is needed to help providers identify and support individuals at risk for poorer coping and greater practical concerns after treatment completion.

Implications for Cancer Survivors

Identifying individuals with greater supportive needs following treatment for localized PCa treatment will help ensure successful adaptation to new roles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. American Cancer Society. Cancer facts & figures 2019. Atlanta: American Cancer Society 2019.

  2. American Cancer Society. Cancer treatment & survivorship facts & figures. Atlanta: American Cancer Society. 2019.

  3. Mahal BA, Butler S, Franco I, Spratt DE, Rebbeck TR, D’Amico AV, et al. Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015. JAMA. 2019;321(7):704–6.

    PubMed  PubMed Central  Google Scholar 

  4. Baker H, Wellman S, Lavender V. Functional quality-of-life outcomes reported by men treated for localized prostate cancer: a systematic literature review. Oncol Nurs Forum. 2016;43(2):199–218. https://doi.org/10.1188/16.onf.199-218.

    Article  PubMed  Google Scholar 

  5. Paterson C, Robertson A, Smith A, Nabi G. Identifying the unmet supportive care needs of men living with and beyond prostate cancer: a systematic review. Euro J Oncol Nurs. 2015;19(4):405–18.

    Google Scholar 

  6. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol. 2006;24(32):5132–7.

    PubMed  Google Scholar 

  7. Mullan F. Re-entry: the educational needs of the cancer survivor. Health Educ Q. 1984;10(Suppl):88–94.

    PubMed  Google Scholar 

  8. Leach CR, Troeschel AN, Wiatrek D, Stanton AL, Diefenbach M, Stein KD, et al. Preparedness and cancer-related symptom management among cancer survivors in the first year post-treatment. Ann Behav Med. 2017;51(4):587–98.

    PubMed  Google Scholar 

  9. Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30(11):1215–20.

    PubMed  Google Scholar 

  10. Moos R, Schaefer J. In: Goldberger L, Breznitz S, editors. Handbook of stress: Theoretical and clinical aspects. 1993. p. 234–57.

  11. Lazarus R, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.

    Google Scholar 

  12. Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR. Promoting adjustment after treatment for cancer. Cancer. 2005;104(11 Suppl):2608–13.

    PubMed  Google Scholar 

  13. Stergiou-Kita M, Pritlove C, Holness DL, Kirsh B, van Eerd D, Duncan A, et al. Am I ready to return to work? Assisting cancer survivors to determine work readiness. J Cancer Surviv. 2016;10(4):699–710.

    PubMed  Google Scholar 

  14. Miller SM, Hudson SV, Hui SK, Diefenbach MA, Fleisher L, Raivitch S, et al. Development and preliminary testing of PROGRESS: a web-based education program for prostate cancer survivors transitioning from active treatment. J Cancer Surviv. 2015;9(3):541–53.

    PubMed  PubMed Central  Google Scholar 

  15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    CAS  PubMed  Google Scholar 

  16. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.

    PubMed  Google Scholar 

  17. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health. 1993;5(2):179–93.

    CAS  PubMed  Google Scholar 

  18. Schag C, Ganz P, Polinsky M, Fred C, Hirji K, Petersen K. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol. 1993;11(4):783–93.

    CAS  PubMed  Google Scholar 

  19. Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, Hamilton AS, et al. Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns. 2012;89(2):345–52.

    PubMed  PubMed Central  Google Scholar 

  20. Cuevas AG, O'Brien K, Saha S. African American experiences in healthcare: “I always feel like I'm getting skipped over.”. Health Psychol. 2016;35(9):987–95.

    PubMed  Google Scholar 

  21. Moore AD, Hamilton JB, Knafl GJ, Godley PA, Carpenter WR, Bensen JT, et al. The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: the North Carolina-Louisiana Prostate Cancer Project. J Natl Med Assoc. 2013;105(1):59–68.

    PubMed  Google Scholar 

  22. Halbert CH, Weathers B, Delmoor E, Mahler B, Coyne J, Thompson HS, et al. Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer. 2009;115(11):2553–61.

    PubMed  PubMed Central  Google Scholar 

  23. Bustillo NE, McGinty HL, Dahn JR, Yanez B, Antoni MH, Kava BR, et al. Fatalism, medical mistrust, and pretreatment health-related quality of life in ethnically diverse prostate cancer patients. Psychooncology. 2017;26(3):323–9.

    PubMed  Google Scholar 

  24. Hansen BR, Hodgson NA, Gitlin LN. It's a matter of trust: older African Americans speak about their health care encounters. J Appl Gerontol. 2016;35(10):1058–76.

    PubMed  Google Scholar 

  25. Penner LA, Dovidio JF, Hagiwara N, Foster T, Albrecht TL, Chapman RA et al. An analysis of race-related attitudes and beliefs in black cancer patients.

  26. Kinlock BL, Parker LJ, Bowie JV, Howard DL, LaVeist TA, Thorpe RJ Jr. High levels of medical mistrust are associated with low quality of life among Black and White men with prostate cancer. Cancer Control. 2017;24(1):72–7.

    PubMed  Google Scholar 

  27. Maina IW, Belton TD, Ginzberg S, Singh A, Johnson TJ. A decade of studying implicit racial/ethnic bias in healthcare providers using the implicit association test. Soc Sci Med. 2018;199:219–29.

    PubMed  Google Scholar 

  28. Penner LA, Dovidio JF, Gonzalez R, Albrecht TL, Chapman R, Foster T, et al. The effects of oncologist implicit racial bias in racially discordant oncology interactions. J Clin Oncol. 2016;34(24):2874–80.

    PubMed  PubMed Central  Google Scholar 

  29. McDowell BD, Klemp J, Blaes A, Cohee AA, Trentham-Dietz A, Kamaraju S, et al. The association between cancer care coordination and quality of life is stronger for breast cancer patients with lower health literacy: a Greater Plains collaborative study. Support Care Cancer. 2019.

  30. Halverson JL, Martinez-Donate AP, Palta M, Leal T, Lubner S, Walsh MC, et al. Health literacy and health-related quality of life among a population-based sample of cancer patients. J Health Comm. 2015;20(11):1320–9.

    Google Scholar 

  31. Song L, Mishel M, Bensen JT, Chen RC, Knafl GJ, Blackard B, et al. How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer? Findings from the North Carolina-Louisiana Prostate Cancer Project (PCaP). Cancer. 2012;118(15):3842–51.

    PubMed  Google Scholar 

  32. Mora-Pinzon MC, Chrischilles EA, Greenlee RT, Hoeth L, Hampton JM, Smith MA, et al. Variation in coordination of care reported by breast cancer patients according to health literacy. Support Care Cancer. 2019;27(3):857–65.

    PubMed  Google Scholar 

  33. McKenna VB, Sixsmith J, Barry MM. The relevance of context in understanding health literacy skills: findings from a qualitative study. Health Expect. 2017;20(5):1049–60.

    PubMed  PubMed Central  Google Scholar 

  34. Allenbaugh J, Spagnoletti CL, Rack L, Rubio D, Corbelli J. Health literacy and clear bedside communication: a curricular intervention for internal medicine physicians and medicine nurses. MedEdPORTAL. 2019;15:10795.

    PubMed  PubMed Central  Google Scholar 

  35. Zafar SY. Financial toxicity of cancer care: it's time to intervene. J Natl Cancer Inst. 2016;108(5).

  36. Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst. 2017;109(2).

  37. Dean LT, Moss SL, Rollinson SI, Frasso Jaramillo L, Paxton RJ, Owczarzak JT. Patient recommendations for reducing long-lasting economic burden after breast cancer. Cancer. 2019;125(11):1929–40.

    PubMed  PubMed Central  Google Scholar 

  38. Inhestern L, Beierlein V, Bultmann JC, Moller B, Romer G, Koch U, et al. Anxiety and depression in working-age cancer survivors: a register-based study. BMC Cancer. 2017;17(1):347.

    PubMed  PubMed Central  Google Scholar 

  39. Erim DO, Bensen JT, Mohler JL, Fontham ETH, Song L, Farnan L, et al. Prevalence and predictors of probable depression in prostate cancer survivors. Cancer. 2019;125(19):3418–27.

    PubMed  PubMed Central  Google Scholar 

  40. Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4(3):e003901.

    PubMed  PubMed Central  Google Scholar 

  41. Stommel M, Kurtz ME, Kurtz JC, Given CW, Given BA. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol. 2004;23(6):564–73.

    PubMed  Google Scholar 

  42. Deimling GT, Brown SP, Albitz C, Burant CJ, Mallick N. The relative importance of cancer-related and general health worries and distress among older adult, long-term cancer survivors. Psychooncology. 2017;26(2):182–90.

    PubMed  Google Scholar 

  43. Alwhaibi M, Madhavan S, Bias T, Kelly K, Walkup J, Sambamoorthi U. Depression treatment among elderly medicare beneficiaries with incident cases of cancer and newly diagnosed depression. Psychiatr Serv. 2017;68(5):482–9.

    PubMed  PubMed Central  Google Scholar 

  44. Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can't pay the co-pay. Patient. 2017;10(3):295–309.

    PubMed  Google Scholar 

  45. McLennan V, Ludvik D, Chambers S, Frydenberg M. Work after prostate cancer: a systematic review. J Cancer Surviv. 2019;13(2):282–91.

    PubMed  Google Scholar 

  46. Dahl S, Cvancarova M, Dahl AA, Fossa SD. Work ability in prostate cancer survivors after radical prostatectomy. Scand J Urol. 2016;50(2):116–22.

    PubMed  Google Scholar 

  47. Farris MS, Kopciuk KA, Courneya KS, McGregor SE, Wang Q, Friedenreich CM. Identification and prediction of health-related quality of life trajectories after a prostate cancer diagnosis. Intl J Cancer. 2017;140(7):1517–27.

    CAS  Google Scholar 

  48. Song L, Ji Y, Nielsen ME. Quality of life and health status among prostate cancer survivors and noncancer population controls. Urology. 2014;83(3):658–63.

    PubMed  PubMed Central  Google Scholar 

  49. Lee TK, Breau RH, Mallick R, Eapen L. A systematic review of expanded prostate cancer index composite (EPIC) quality of life after surgery or radiation treatment. Can J Urol. 2015;22(1):7599–606.

    PubMed  Google Scholar 

  50. Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fossa SD. Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery. J Cancer Surviv. 2015;9(2):172–9.

    PubMed  Google Scholar 

  51. Hays LH, McSweeney JC, Mitchell A, Bricker C, Green A, Landes RD. Self-management needs of adults with congenital heart disease. J Cardiovasc Nurs. 2020.

  52. Damery S, Sein K, Nicholas J, Baharani J, Combes G. The challenge of managing mild to moderate distress in patients with end stage renal disease: results from a multi-centre, mixed methods research study and the implications for renal service organisation. BMC Health Serv Res. 2019;19(1):989.

    PubMed  PubMed Central  Google Scholar 

  53. Porter AC, Lash JP, Xie D, Pan Q, DeLuca J, Kanthety R, et al. Predictors and outcomes of health-related quality of life in adults with CKD. Clin J Am Soc Nephrol. 2016;11(7):1154–62.

    PubMed  PubMed Central  Google Scholar 

  54. Weaver KR, Melkus GD, Fletcher J, Henderson WA. Perceived stress, its physiological correlates, and quality of life in patients with irritable bowel syndrome. Biol Res Nurs. 2018;20(3):312–20.

    PubMed  PubMed Central  Google Scholar 

  55. Warzecha D, Szymusik I, Wielgos M, Pietrzak B. The impact of endometriosis on the quality of life and the incidence of depression-a cohort study. Int J Environ Res Public Health. 2020;17(10).

  56. Wen KY, Fang CY, Ma GX. Breast cancer experience and survivorship among Asian Americans: a systematic review. J Cancer Surviv. 2014;8(1):94–107.

    Google Scholar 

  57. Martin DN, Lam TK, Brignole K, Ashing KT, Blot WJ, Burhansstipanov L, et al. Recommendations for cancer epidemiologic research in understudied populations and implications for future needs. Cancer Epidemiol Biomark Prev. 2016;25(4):573–80.

    Google Scholar 

  58. Dowsett G, Duncan D, Du Plooy D, Waling A, Prestage G. Gay men, sexuality and mental health after prostate cancer. J of Sexual Med. 2017;14(5):e248.

    Google Scholar 

  59. Ussher JM, Perz J, Kellett A, Chambers S, Latini D, Davis ID, et al. Health-related quality of life, psychological distress, and sexual changes following prostate cancer: a comparison of gay and bisexual men with heterosexual men. J Sex Med. 2016;13(3):425–34.

    PubMed  Google Scholar 

  60. Torbit LA, Albiani JJ, Crangle CJ, Latini DM, Hart TL. Fear of recurrence: the importance of self-efficacy and satisfaction with care in gay men with prostate cancer. Psycho-oncology. 2015;24(6):691–8.

    PubMed  Google Scholar 

  61. Jabson JM, Kamen CS. Sexual minority cancer survivors' satisfaction with care. J Psychosocial Oncology. 2016;34(1–2):28–38.

    Google Scholar 

  62. Cathcart-Rake EJ. Cancer in sexual and gender minority patients: are we addressing their needs? Curr Oncol Rep. 2018;20(11):85.

    PubMed  Google Scholar 

Download references

Acknowledgments

We thank all participating cancer centers, oncologists, clinical staff, and research staff that contributed to the completion of this study.

Funding

The study was funded by the National Cancer Institute (R01CA224918, P30CA006927, P30CA072720, and T32CA009035), the National Center for Advancing Translational Sciences (UL1TR003017), the Centers for Disease Control and Prevention (U01OH011690), and the American Cancer Society (RSG-15-021-01-CPPB).

Author information

Authors and Affiliations

  1. Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, 19111, USA

    Erin K. Tagai, Jenny Xu & Suzanne M. Miller

  2. Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, 125 Patterson St, New Brunswick, NJ, 08901, USA

    Shawna V. Hudson & Alicja Bator

  3. Division of Population Science, Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA

    Shawna V. Hudson

  4. Center for Health Innovation and Outcomes Research, Feinstein Institute for Medical Research, Northwell Health, 300 Community Dr, Manhasset, NY, 11030, USA

    Michael A. Diefenbach & Allison Marziliano

Authors
  1. Erin K. Tagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shawna V. Hudson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael A. Diefenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jenny Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alicja Bator
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Allison Marziliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Suzanne M. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suzanne M. Miller.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tagai, E.K., Hudson, S.V., Diefenbach, M.A. et al. Social and medical risk factors associated with supportive needs in the first year following localized prostate cancer treatment. J Cancer Surviv 15, 110–118 (2021). https://doi.org/10.1007/s11764-020-00916-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-020-00916-5

Keywords

Search

Navigation